Zacks Research Forecasts Lower Earnings for AngioDynamics

AngioDynamics, Inc. (NASDAQ:ANGO) – Investment analysts at Zacks Research reduced their Q3 2027 earnings per share (EPS) estimates for shares of AngioDynamics in a note issued to investors on Thursday, April 23rd. Zacks Research analyst Team now expects that the medical instruments supplier will earn $0.02 per share for the quarter, down from their prior forecast of $0.03. Zacks Research has a “Hold” rating on the stock. The consensus estimate for AngioDynamics’ current full-year earnings is ($0.20) per share.

AngioDynamics (NASDAQ:ANGO) last announced its earnings results on Thursday, April 2nd. The medical instruments supplier reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.04. AngioDynamics had a negative return on equity of 4.66% and a negative net margin of 10.01%.The firm had revenue of $78.42 million for the quarter, compared to the consensus estimate of $76.77 million.

Several other equities research analysts also recently weighed in on the stock. Canaccord Genuity Group reduced their price objective on shares of AngioDynamics from $18.00 to $16.00 and set a “buy” rating for the company in a report on Monday, April 6th. Freedom Capital upgraded shares of AngioDynamics to a “strong-buy” rating in a research report on Monday, April 6th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of AngioDynamics in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $18.67.

AngioDynamics Stock Performance

NASDAQ:ANGO opened at $11.20 on Friday. The stock has a market cap of $462.78 million, a price-to-earnings ratio of -14.93 and a beta of 0.43. AngioDynamics has a 1 year low of $8.36 and a 1 year high of $13.99. The business has a fifty day moving average of $10.82 and a 200-day moving average of $11.49.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Divisadero Street Capital Management LP increased its position in shares of AngioDynamics by 8.3% in the third quarter. Divisadero Street Capital Management LP now owns 3,678,125 shares of the medical instruments supplier’s stock worth $41,085,000 after acquiring an additional 282,695 shares in the last quarter. Millennium Management LLC grew its position in AngioDynamics by 28.1% during the 3rd quarter. Millennium Management LLC now owns 1,793,152 shares of the medical instruments supplier’s stock worth $20,030,000 after purchasing an additional 393,682 shares in the last quarter. Kotler Kevin purchased a new position in AngioDynamics during the 4th quarter worth approximately $21,997,000. Armistice Capital LLC raised its stake in AngioDynamics by 3.9% during the 4th quarter. Armistice Capital LLC now owns 1,700,000 shares of the medical instruments supplier’s stock valued at $21,828,000 after purchasing an additional 64,000 shares during the period. Finally, Weber Capital Management LLC ADV purchased a new stake in shares of AngioDynamics in the fourth quarter valued at $17,978,000. 89.43% of the stock is currently owned by institutional investors and hedge funds.

AngioDynamics Company Profile

AngioDynamics, Inc is a medical technology company headquartered in Latham, New York, that develops, manufactures and markets a broad range of minimally invasive medical devices. The company’s products focus on three core areas: vascular access, peripheral vascular intervention and interventional oncology. Its solutions are designed to improve procedural outcomes, reduce complications and enhance patient comfort in hospital and outpatient settings.

In the vascular access segment, AngioDynamics offers a portfolio of devices including implanted ports, peripherally inserted central catheters (PICCs), hemodialysis catheters and specialty blood management products.